Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other financing activities (2016 - 2024)

Historic Other financing activities for Utah Medical Products (UTMD) over the last 15 years, with Q4 2024 value amounting to $1000.0.

  • Utah Medical Products' Other financing activities changed N/A to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9500.0%. This contributed to the annual value of $21000.0 for FY2024, which is 7500.0% up from last year.
  • Per Utah Medical Products' latest filing, its Other financing activities stood at $1000.0 for Q4 2024.
  • In the past 5 years, Utah Medical Products' Other financing activities ranged from a high of $28000.0 in Q4 2021 and a low of $1000.0 during Q4 2024
  • Moreover, its 5-year median value for Other financing activities was $5500.0 (2021), whereas its average is $7083.3.
  • Per our database at Business Quant, Utah Medical Products' Other financing activities plummeted by 7857.14% in 2022 and then soared by 35000.0% in 2024.
  • Utah Medical Products' Other financing activities (Quarter) stood at $4000.0 in 2020, then skyrocketed by 600.0% to $28000.0 in 2021, then plummeted by 78.57% to $6000.0 in 2022, then tumbled by 50.0% to $3000.0 in 2023, then plummeted by 66.67% to $1000.0 in 2024.
  • Its Other financing activities stands at $1000.0 for Q4 2024, versus $11000.0 for Q2 2024 and $9000.0 for Q1 2024.